Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2021 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The question asks: does management convey that deals, orders, contracts, projects, customers, sites, or programs it is landing NOW are individually bigger, broader, or longer than the ones it was landing for the same offering not long ago, so that each new instance of essentially the same business is worth more to the company than the last? We need to look for any statement about the size of individual orders, contracts, deals, etc., escalating. The transcript mentions strong demand, record backlog, order rates, but does it specifically say that the size of individual engagements is growing? For example, "book to build well above 1", "backlog at record levels", "global order rates strong", "January highest monthly order rate in company's history". These are about volume, not necessarily unit size. There is mention of "key wins" and "design wins" but no comparison of size of those wins versus past. There is mention of "incremental capacity" and "new business" but not about larger individual deals. The question specifically asks about "successive engagements of the same kind coming in at progressively larger size". The transcript does not contain any statement like "average order size has increased" or "customers are now starting with larger commitments". There is no comparison of deal size over time. The only possible hint is "book to build well above 1" which means orders exceed shipments, but that's about volume, not size per order. Also "backlog at record levels" could be due to more orders or larger orders, but not specified. Management does mention "we are making good progress on adding incremental capacity for some of the most constrained products" and "we anticipate that we should be getting -- we should start making some progress on eating into the backlog." That's about supply constraints, not about deal size escalation. There is also mention of "key wins" in semiconductor processing equipment, warehouse automation, robotics, and a strategic relationship with Gogoro, and a win with an electric vehicle manufacturer. But no indication that these are larger than previous wins. They are just new wins. Thus, the answer is NO. The management does not convey that the individual size of engagements is escalating.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.